{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Morrison SL"],"funding":["NEI NIH HHS"],"pagination":["401-409"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8931675"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["140(4)"],"pubmed_abstract":["<h4>Importance</h4>Artificial intelligence (AI)-based retinopathy of prematurity (ROP) screening may improve ROP care, but its cost-effectiveness is unknown.<h4>Objective</h4>To evaluate the relative cost-effectiveness of autonomous and assistive AI-based ROP screening compared with telemedicine and ophthalmoscopic screening over a range of estimated probabilities, costs, and outcomes.<h4>Design, setting, and participants</h4>A cost-effectiveness analysis of AI ROP screening compared with ophthalmoscopy and telemedicine via economic modeling was conducted. Decision trees created and analyzed modeled outcomes and costs of 4 possible ROP screening strategies: ophthalmoscopy, telemedicine, assistive AI with telemedicine review, and autonomous AI with only positive screen results reviewed. A t"],"journal":["JAMA ophthalmology"],"pubmed_title":["Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening."],"pmcid":["PMC8931675"],"funding_grant_id":["R01 EY031331","R01 EY019474"],"pubmed_authors":["Chan RVP","Morrison SL","Chiang MF","Campbell JP","Dukhovny D"],"additional_accession":[]},"is_claimable":false,"name":"Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.","description":"<h4>Importance</h4>Artificial intelligence (AI)-based retinopathy of prematurity (ROP) screening may improve ROP care, but its cost-effectiveness is unknown.<h4>Objective</h4>To evaluate the relative cost-effectiveness of autonomous and assistive AI-based ROP screening compared with telemedicine and ophthalmoscopic screening over a range of estimated probabilities, costs, and outcomes.<h4>Design, setting, and participants</h4>A cost-effectiveness analysis of AI ROP screening compared with ophthalmoscopy and telemedicine via economic modeling was conducted. Decision trees created and analyzed modeled outcomes and costs of 4 possible ROP screening strategies: ophthalmoscopy, telemedicine, assistive AI with telemedicine review, and autonomous AI with only positive screen results reviewed. A t","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-04T12:28:57.092Z","creation":"2025-04-04T12:28:57.092Z"},"accession":"S-EPMC8931675","cross_references":{"pubmed":["35297945"],"doi":["10.1001/jamaophthalmol.2022.0223"]}}